Thomas H. Kean Periodic Transaction Report

Filed Mar 11, 2023 · House Clerk · 2 transactions

U.S. Representative · R · NJ-07 · All trades by Thomas H. Kean

On March 11, 2023, Rep. Thomas H. Kean (R-NJ-07) filed a periodic transaction report with the House Clerk disclosing 2 transactions (2 sales) dated Feb 24, 2023.

The filing covers 2 tickers, including $JNJ, $SYK.

Reported amount ranges sum to $30K–$100K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 15 days.

Source document: House Clerk filing 20022550

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Thomas H. Kean · Sold $JNJ · Feb 24 · $15K–$50K

0.65MED
Disclosure speedx 0.250.60
Trade sizex 0.250.50
Cluster activityx 0.151.00

3 other members traded this name in the same window.

Track recordx 0.350.63

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Thomas H. Kean

Get an email the moment Thomas H. Kean files the next one. Free, no card, no spam.

Follow free →
2
Transactions
0 / 2
Buys / sales
2
Tickers
15d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Feb 24, 2023JNJ
Johnson & Johnson (JNJ)
sell—$15K–$50K15d
Feb 24, 2023SYK
Stryker Corporation (SYK)
sell—$15K–$50K15d

The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.

Other recent filings by Thomas H. Kean

← All congressional filings, newest firstFiled Mar 11, 2023March 2023 archive

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →